IRIS
LUCARELLI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.945
AS - Asia 4.260
EU - Europa 3.723
SA - Sud America 1.237
Continente sconosciuto - Info sul continente non disponibili 652
AF - Africa 203
OC - Oceania 6
AN - Antartide 1
Totale 23.027
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.543
SG - Singapore 1.664
IT - Italia 1.384
BR - Brasile 993
CN - Cina 910
HK - Hong Kong 539
SE - Svezia 452
RU - Federazione Russa 446
VN - Vietnam 363
DE - Germania 335
FR - Francia 239
GB - Regno Unito 217
FI - Finlandia 206
CA - Canada 189
BD - Bangladesh 159
IN - India 142
UA - Ucraina 141
AR - Argentina 86
IQ - Iraq 67
BE - Belgio 62
ID - Indonesia 60
CO - Colombia 53
MX - Messico 50
LT - Lituania 49
ZA - Sudafrica 48
TR - Turchia 46
SA - Arabia Saudita 41
JP - Giappone 40
CI - Costa d'Avorio 37
NL - Olanda 35
PK - Pakistan 35
VE - Venezuela 31
EC - Ecuador 30
ES - Italia 29
CR - Costa Rica 25
PL - Polonia 24
IE - Irlanda 23
PH - Filippine 23
HN - Honduras 22
TT - Trinidad e Tobago 21
MA - Marocco 19
GT - Guatemala 18
TN - Tunisia 18
UZ - Uzbekistan 18
MY - Malesia 15
SC - Seychelles 15
GP - Guadalupe 14
KE - Kenya 14
EG - Egitto 13
IR - Iran 13
JM - Giamaica 13
JO - Giordania 13
NI - Nicaragua 13
SV - El Salvador 13
AE - Emirati Arabi Uniti 12
AT - Austria 12
IL - Israele 11
NP - Nepal 11
AZ - Azerbaigian 10
CL - Cile 10
CW - ???statistics.table.value.countryCode.CW??? 10
KR - Corea 9
OM - Oman 9
PY - Paraguay 9
CH - Svizzera 8
PE - Perù 8
TH - Thailandia 8
UY - Uruguay 8
BO - Bolivia 7
KZ - Kazakistan 7
PR - Porto Rico 7
AL - Albania 6
DZ - Algeria 6
LB - Libano 6
PS - Palestinian Territory 6
RO - Romania 6
AU - Australia 5
CZ - Repubblica Ceca 5
ET - Etiopia 5
RS - Serbia 5
SN - Senegal 5
SY - Repubblica araba siriana 5
AO - Angola 4
BB - Barbados 4
BG - Bulgaria 4
BY - Bielorussia 4
EE - Estonia 4
GE - Georgia 4
AM - Armenia 3
BF - Burkina Faso 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
AW - Aruba 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
EU - Europa 2
GA - Gabon 2
GR - Grecia 2
Totale 22.338
Salva come PNG Salva come JPEG
Città #
Ashburn 1.504
Fairfield 1.261
Woodbridge 902
Singapore 897
Chandler 788
San Jose 699
Houston 599
Hong Kong 537
Seattle 525
Cambridge 476
Milan 408
Wilmington 387
Nyköping 357
Ann Arbor 326
Beijing 307
Jacksonville 281
New York 251
Council Bluffs 250
Los Angeles 193
Bari 167
Rome 158
Lawrence 155
Roxbury 155
Dallas 151
Lauterbourg 147
São Paulo 119
Munich 118
Ho Chi Minh City 117
Santa Clara 114
Nanjing 113
Des Moines 99
Princeton 87
Helsinki 81
Hanoi 70
Boardman 68
Buffalo 67
Brooklyn 62
Brussels 60
Columbus 60
London 60
San Diego 57
Inglewood 52
Dearborn 45
Montreal 44
Atlanta 43
Chicago 43
Figino 42
Frankfurt am Main 39
Jakarta 38
Phoenix 38
Vilnius 38
Abidjan 37
The Dalles 37
Shenyang 36
Dong Ket 35
Turin 35
Hebei 34
Toronto 33
Redwood City 32
Rio de Janeiro 31
Tokyo 30
Orem 29
Turku 29
Paris 28
Nanchang 27
Boston 26
Dublin 26
Baghdad 25
Pune 25
Brasília 24
Jiaxing 24
North Bergen 24
Tianjin 24
San Francisco 23
Falkenstein 22
Belo Horizonte 21
Campinas 21
Moscow 21
Washington 21
Bologna 20
Denver 20
Naples 20
Changsha 19
Mexico City 19
Stockholm 19
Augusta 17
Chennai 17
Curitiba 17
Guangzhou 17
Warsaw 17
Jeddah 16
Johannesburg 16
Medellín 16
Bogotá 15
Caracas 15
Nuremberg 15
San José 15
Tashkent 15
Amsterdam 14
Bitonto 14
Totale 14.788
Salva come PNG Salva come JPEG
Nome #
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 277
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 240
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 240
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 235
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 228
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 222
B3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Insipidus 220
Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function 218
Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury 218
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 216
Clinical management of a unique case of PNET of the uterus during pregnancy, and review of the literature 215
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 211
Isolation and characterization of cancer stem cells in renal cell carcinoma. 208
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 207
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation. 193
Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study 189
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 184
Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report 184
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 184
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 180
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 177
Allograft nephrectomy: what is the best surgical technique? 177
Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. 176
Androgen deprivation therapy affects BCL-2 expression in human prostate cancer 176
Complement activation during ischemia/reperfusion injury induces pericyte-to-myofibroblast transdifferentiation regulating peritubular capillary Lumen Reduction Through pERK Signaling 176
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 172
Capillary hemangioma of the scrotum mimicking an epididymal tumor: case report. 170
Penile prosthesis implant: when, what and how 170
Experience of percutaneous access under ultrasound guidance in renal transplant patients with allograft lithiasis 169
A challenging surgical approach to locally advanced primary urethral carcinoma: A case report and literature review 165
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 164
DIABETES MELLITUS IN RENAL CELL CARCINOMA: ROLE OF OGG1 AND TUBERIN 162
DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via Complement-mediated cellular senescence 162
Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years 157
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 156
Androgen deprivation therapy regulation of beta 1C integrin expression in prostate cancer 153
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 153
ASSOCIATION OF N-ACETYLTRANSFERASE 2 POLYMORPHISM WITH RISK FACTORS IN UROTHELIAL CANCER. 151
A CLUSTER OF PROTEINS SECRETED BY HUMAN RENAL STEM/PROGENITOR CELLS (ARPCS) PROVIDE A NOVEL STRATEGY TO REVERT ENDOTHELIAL DYSFUNCTION AND RENAL INJURY IN SEPSIS-INDUCED ACUTE KIDNEY INJURY (AKI) 149
"Deviceless" hand-assisted laparoscopic donor nephrectomy 148
PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma 148
Emerging urinary markers of renal injury in obstructive nephropathy. 147
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 147
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage 146
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. 146
Complement-Mediated Acute Induction of Endothelial-to-Mesenchymal Transition in a Swine Model of Renal Ischemia/Reperfusion (I/R) Injury 144
Penile prosthesis: what should we do about complications? 142
Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction 141
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review 140
DIABETES MELLITUS IS A RISK FACTOR FOR RECURRENCE AND MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA . 139
Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma 139
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 139
Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury 139
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 138
Extended Criteria Donor Kidney Transplantation: Comparative Outcome Analysis of Score 4 Graft Used as Single Transplant Versus Double Kidney Transplantation 135
The emerging role of obesity, diet and lipid metabolism in prostate cancer 134
Patient and partner satisfaction after AMS inflatable penile prosthesis implant 132
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 132
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 132
Incidental prostatic cancer: repeat TURP or biopsy? 131
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome 131
Obesity in kidney transplantation affects renal function but not graft and patient survival 130
Management of severe complications following penile surgery for erectile dysfunction and Peyronie disease: Three case reports 130
Emerging biomarkers in renal damage. 129
Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population. 129
Editorial comment from Dr Lucarelli and Dr Ditonno to Impact of graft nephrectomy on outcomes of second kidney transplantation. 127
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 127
Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway 126
Middle and long-term outcomes of dual kidney transplant: a multicenter experience 125
Ischemia-Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets. 124
Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study 123
LOSS OF LKB1 EXPRESSION IS AN EARLY MOLECULAR EVENT IN PROSTATE CARCINOGENESIS 123
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 123
Hem-O-Lok clip: A neglected cause of severe bladder neck contracture and consequent urinary incontinence after robot-assisted laparoscopic radical prostatectomy 120
null 119
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer 119
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation 118
36-kDa Annexin A3 Isoform Negatively Modulates Lipid Storage in Clear Cell Renal Cell Carcinoma Cells 118
CARCINOMA DELLA PROSTATA 117
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 117
Complement Mediated Endothelial Cell (EC) Activation in a Swine Model of Renal Ischemia/Reperfusion (I/R) Injury 117
Transperitoneal deviceless hand-assisted laparoscopic living donor nephrectomy: an alternative technique for kidney recovery 117
Aligned Nanofiber Topographies Enhance the Differentiation of Adult Renal Stem Cells into Glomerular Podocytes 116
The Role of MUC1 in Renal Cell Carcinoma. Biomolecules. 115
An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas 114
LAMININA 5 COME MARKER NELLA DIAGNOSI E NELLA PROGNOSI DEL CARCINOMA UROTELIALE DELLA VESCICA 113
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 112
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 111
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 111
Incidentally discovered yellowish lesions in a renal graft from a deceased donor 111
DIABETES MELLITUS IS A RISK FACTOR FOR PROGRESSION IN RENAL CELL CARCINOMA 110
RENAL CELL CARCINOMA: DOES TRANSCRIPTIONAL DEREGULATION OF ADULT RENAL STEM/PROGENITOR CELLS LEAD TO ONCOGENESIS? 110
null 109
Kinetics of humoral immune response and severity of infection after three doses of SARS-CoV-2 mRNA vaccine in a large cohort of kidney transplant recipients 108
THE DIAGNOSTIC ROLE OF CA 15-3, CA 125 AND BETA2-MICROGLOBULIN IN RENAL CELL CARCINOMA 108
Testicular granulosa cell tumor of adult type: a new case and a review of the literature 107
Impact of transplant nephrectomy on retransplantation: a single-center retrospective study. 104
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer 104
Platelet-rich plasma intra-plaque injections rapidly reduce penile curvature and improve sexual function in Peyronie's disease patients: results from a prospective large-cohort study 104
CTR2 Identifies a Population of Cancer Cells with Stem-Like Features in Patients with Clear Cell Renal Cell Carcinoma. 103
Totale 15.022
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.567
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022890 0 0 0 0 42 103 42 64 71 118 164 286
2022/20231.890 288 228 129 171 187 259 25 239 279 16 45 24
2023/2024663 65 120 38 49 57 230 10 13 5 14 11 51
2024/20253.069 70 73 221 124 88 285 371 271 114 134 455 863
2025/20266.843 1.015 306 449 751 812 359 673 214 631 618 264 751
2026/20272.774 146 353 630 1.566 79 0 0 0 0 0 0 0
Totale 23.027